Data recap: Tech talent, drug quality checks, gherkin exports, MF deals and more
Mint in the week gone by. The revenue contributed by an average employee at top software services companies has been consistently falling ever since the covid-19 pandemic ended, with increased hiring and plateauing revenue. And the popularity of Indian gherkins is growing globally owing to its many health benefits.
The per-employee revenue at leading information technology (IT) services firms has declined steadily since the covid-19 pandemic, a Mint report said. During the pandemic, businesses all over the world rushed to digitise their operations and IT firms hired vigorously to meet the demand. Though the pandemic is now over, many of these new employees are still on the rolls even as revenue growth has stalled since the highs of the pandemic.
The Central Drugs Standard Control Organisation (CDSCO)—the apex regulatory authority for the pharmaceuticals, medical devices, and cosmetics industries — is gradually updating the process of approving pharma exports, Mint reported, quoting unnamed officials. This was in response to concerns from global authorities over the quality and safety of medicines from India. States may now be allowed to issue certificates to pharma companies only if CDSCO officials are involved in joint inspections.
$189.08 million: That's the value of gherkins—pickled baby cucumbers—exported from India in the 10 months to January in FY24, Mint reported. India's gherkins being savoured across Europe and countries such as the US, South Korea and Brazil. As of January, India exported gherkins worth $15.66 million to Germany, the top importer after the US.
Read more on livemint.com
